Professor Amy Berrington’s team is investigating the late-effects of cancer treatments, medical radiation exposures and other medications to improve outcomes for patients.
Professor Amy Berrington is an expert in the use of real world data to study the late-effects of cancer treatments, medical radiation exposures and other medications. She is a member of several national and international advisory boards and was recently appointed Vice-Chair of the US National Academy of Science Nuclear and Radiation Studies Board.